Advertisement
Screener

NeuroOne Medical Technologies Corporation (NMTC) Deferred Revenue Recognized

2.8 / 5 stars · 68/120 Roast Me

NeuroOne Medical Technologies Corporation Deferred Revenue Recognized

NeuroOne Medical Technologies Corporation (NMTC) reported Deferred Revenue Recognized of -$1.46 million for the 12-month period ending 2023-09-30, per its 10-K filed 2024-12-17.

Financial Statements › Income Statement › Other Income

us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2024-12-17

  • NeuroOne Medical Technologies Corporation contract with customer, liability, revenue recognized for fiscal 2023 was -$1.46M.
  • NeuroOne Medical Technologies Corporation contract with customer, liability, revenue recognized for fiscal 2022 was -$1.95M.
Period endContract with Customer, Liability, Revenue Recognized 6 monthContract with Customer, Liability, Revenue Recognized 9 monthContract with Customer, Liability, Revenue Recognized 12 month
2023-09-30-$1.46M
10-K · filed 2024-12-17
2023-06-30-$1.46M
10-Q · filed 2023-08-14
2023-03-31$1.46M
10-Q · filed 2023-05-12
2022-09-30-$1.95M
10-K · filed 2023-12-15
2022-06-30-$6.37K
10-Q · filed 2023-08-14
2022-03-31$6.37K
10-Q · filed 2023-05-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sintx Technologies, Inc. (SINT)United States$0.012B-1.10
Picard Medical, Inc. (PMI)United States$0.011B-0.01
ALLURION TECHNOLOGIES, INC. (ALUR)United States$0.010B
CERENOME, INC. (CNSY)United States$0.014B
SeaStar Medical Holding Corp (ICU)United States$0.015B-1.14
Co-Diagnostics, Inc. (CODX)United States$0.007B-0.32
Modular Medical, Inc. (MODD)United States$0.018B-0.88
enVVeno Medical Corp (NVNO)United States$0.006B-0.48
Sonoma Pharmaceuticals, Inc. (SNOA)United States$0.006B-2.59
INTELLIGENT BIO SOLUTIONS INC. (INBS)United States$0.005B